OTCMKTS:HYBE

Hybrid Energy Competitors

$0.0007
0.00 (0.00 %)
(As of 04/21/2021 01:35 PM ET)
Add
Compare
Today's Range
$0.00
Now: $0.00
$0.00
50-Day Range N/A
52-Week Range
$0.00
Now: $0.00
$0.00
Volume7.46 million shs
Average Volume17.29 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Beta6.78

Competitors

Hybrid Energy (OTCMKTS:HYBE) Vs. FMS, DVA, SHC, PGNY, TVTY, and OTRK

Should you be buying HYBE stock or one of its competitors? Companies in the industry of "miscellaneous health & allied services, not elsewhere classified" are considered alternatives and competitors to Hybrid Energy, including Fresenius Medical Care AG & Co. KGaA (FMS), DaVita (DVA), Sotera Health (SHC), Progyny (PGNY), Tivity Health (TVTY), and Ontrak (OTRK).

Hybrid Energy (OTCMKTS:HYBE) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, institutional ownership, valuation, risk and profitability.

Volatility & Risk

Hybrid Energy has a beta of 6.78, indicating that its stock price is 578% more volatile than the S&P 500. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 1.21, indicating that its stock price is 21% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent recommendations and price targets for Hybrid Energy and Fresenius Medical Care AG & Co. KGaA, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Hybrid Energy0000N/A
Fresenius Medical Care AG & Co. KGaA19702.35

Fresenius Medical Care AG & Co. KGaA has a consensus price target of $48.00, indicating a potential upside of 22.42%. Given Fresenius Medical Care AG & Co. KGaA's higher probable upside, analysts clearly believe Fresenius Medical Care AG & Co. KGaA is more favorable than Hybrid Energy.

Valuation and Earnings

This table compares Hybrid Energy and Fresenius Medical Care AG & Co. KGaA's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hybrid EnergyN/AN/AN/AN/AN/A
Fresenius Medical Care AG & Co. KGaA$19.58 billion1.17$1.34 billion$2.5315.50

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Hybrid Energy.

Profitability

This table compares Hybrid Energy and Fresenius Medical Care AG & Co. KGaA's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Hybrid EnergyN/AN/AN/A
Fresenius Medical Care AG & Co. KGaA7.38%10.62%4.15%

Institutional & Insider Ownership

1.6% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. 6.0% of Hybrid Energy shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Fresenius Medical Care AG & Co. KGaA beats Hybrid Energy on 7 of the 9 factors compared between the two stocks.

Hybrid Energy (OTCMKTS:HYBE) and DaVita (NYSE:DVA) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, valuation, earnings, analyst recommendations, profitability, institutional ownership and risk.

Risk & Volatility

Hybrid Energy has a beta of 6.78, indicating that its share price is 578% more volatile than the S&P 500. Comparatively, DaVita has a beta of 1.3, indicating that its share price is 30% more volatile than the S&P 500.

Valuation & Earnings

This table compares Hybrid Energy and DaVita's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hybrid EnergyN/AN/AN/AN/AN/A
DaVita$11.39 billion1.09$810.98 million$5.4021.03

DaVita has higher revenue and earnings than Hybrid Energy.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Hybrid Energy and DaVita, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Hybrid Energy0000N/A
DaVita12102.00

DaVita has a consensus price target of $124.50, suggesting a potential upside of 9.65%. Given DaVita's higher possible upside, analysts plainly believe DaVita is more favorable than Hybrid Energy.

Profitability

This table compares Hybrid Energy and DaVita's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Hybrid EnergyN/AN/AN/A
DaVita7.32%43.99%5.27%

Institutional and Insider Ownership

91.7% of DaVita shares are held by institutional investors. 6.0% of Hybrid Energy shares are held by insiders. Comparatively, 1.0% of DaVita shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

DaVita beats Hybrid Energy on 7 of the 9 factors compared between the two stocks.

Sotera Health (NYSE:SHC) and Hybrid Energy (OTCMKTS:HYBE) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, earnings, institutional ownership, dividends, valuation and risk.

Profitability

This table compares Sotera Health and Hybrid Energy's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Sotera HealthN/AN/AN/A
Hybrid EnergyN/AN/AN/A

Analyst Ratings

This is a summary of recent ratings and price targets for Sotera Health and Hybrid Energy, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Sotera Health001003.00
Hybrid Energy0000N/A

Sotera Health presently has a consensus target price of $32.75, suggesting a potential upside of 29.50%. Given Sotera Health's higher possible upside, equities research analysts plainly believe Sotera Health is more favorable than Hybrid Energy.

Valuation and Earnings

This table compares Sotera Health and Hybrid Energy's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sotera HealthN/AN/AN/AN/AN/A
Hybrid EnergyN/AN/AN/AN/AN/A

Summary

Sotera Health beats Hybrid Energy on 2 of the 2 factors compared between the two stocks.

Hybrid Energy (OTCMKTS:HYBE) and Progyny (NASDAQ:PGNY) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, valuation, institutional ownership, analyst recommendations, profitability, dividends and earnings.

Profitability

This table compares Hybrid Energy and Progyny's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Hybrid EnergyN/AN/AN/A
Progyny1.03%7.43%5.04%

Institutional and Insider Ownership

58.5% of Progyny shares are held by institutional investors. 6.0% of Hybrid Energy shares are held by insiders. Comparatively, 33.3% of Progyny shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Valuation and Earnings

This table compares Hybrid Energy and Progyny's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hybrid EnergyN/AN/AN/AN/AN/A
Progyny$229.68 million19.15$-8,570,000.00$0.11458.36

Hybrid Energy has higher earnings, but lower revenue than Progyny.

Volatility and Risk

Hybrid Energy has a beta of 6.78, indicating that its stock price is 578% more volatile than the S&P 500. Comparatively, Progyny has a beta of 1.83, indicating that its stock price is 83% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Hybrid Energy and Progyny, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Hybrid Energy0000N/A
Progyny00603.00

Progyny has a consensus target price of $38.8333, suggesting a potential downside of 22.98%. Given Progyny's higher probable upside, analysts plainly believe Progyny is more favorable than Hybrid Energy.

Summary

Progyny beats Hybrid Energy on 8 of the 9 factors compared between the two stocks.

Tivity Health (NASDAQ:TVTY) and Hybrid Energy (OTCMKTS:HYBE) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, profitability, valuation, earnings and risk.

Profitability

This table compares Tivity Health and Hybrid Energy's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Tivity Health-47.44%128.43%6.11%
Hybrid EnergyN/AN/AN/A

Earnings & Valuation

This table compares Tivity Health and Hybrid Energy's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tivity Health$1.13 billion1.04$-286,820,000.00$2.0211.78
Hybrid EnergyN/AN/AN/AN/AN/A

Hybrid Energy has lower revenue, but higher earnings than Tivity Health.

Risk & Volatility

Tivity Health has a beta of 2.49, indicating that its share price is 149% more volatile than the S&P 500. Comparatively, Hybrid Energy has a beta of 6.78, indicating that its share price is 578% more volatile than the S&P 500.

Institutional & Insider Ownership

91.6% of Tivity Health shares are held by institutional investors. 11.8% of Tivity Health shares are held by insiders. Comparatively, 6.0% of Hybrid Energy shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Analyst Ratings

This is a breakdown of current ratings for Tivity Health and Hybrid Energy, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Tivity Health12502.50
Hybrid Energy0000N/A

Tivity Health currently has a consensus price target of $22.1250, suggesting a potential downside of 7.00%. Given Tivity Health's higher probable upside, equities research analysts clearly believe Tivity Health is more favorable than Hybrid Energy.

Summary

Tivity Health beats Hybrid Energy on 7 of the 9 factors compared between the two stocks.

Ontrak (NASDAQ:OTRK) and Hybrid Energy (OTCMKTS:HYBE) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, analyst recommendations and dividends.

Insider and Institutional Ownership

27.5% of Ontrak shares are held by institutional investors. 58.2% of Ontrak shares are held by company insiders. Comparatively, 6.0% of Hybrid Energy shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares Ontrak and Hybrid Energy's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ontrak-43.10%N/A-58.54%
Hybrid EnergyN/AN/AN/A

Analyst Recommendations

This is a summary of current recommendations and price targets for Ontrak and Hybrid Energy, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ontrak02302.60
Hybrid Energy0000N/A

Ontrak currently has a consensus price target of $47.20, suggesting a potential upside of 53.80%. Given Ontrak's higher possible upside, equities analysts clearly believe Ontrak is more favorable than Hybrid Energy.

Valuation and Earnings

This table compares Ontrak and Hybrid Energy's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ontrak$35.10 million15.47$-25,660,000.00($1.15)-26.69
Hybrid EnergyN/AN/AN/AN/AN/A

Hybrid Energy has lower revenue, but higher earnings than Ontrak.

Risk and Volatility

Ontrak has a beta of 2.52, suggesting that its share price is 152% more volatile than the S&P 500. Comparatively, Hybrid Energy has a beta of 6.78, suggesting that its share price is 578% more volatile than the S&P 500.

Summary

Ontrak beats Hybrid Energy on 5 of the 8 factors compared between the two stocks.


Hybrid Energy Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Fresenius Medical Care AG & Co. KGaA logo
FMS
Fresenius Medical Care AG & Co. KGaA
1.7$39.21flat$22.96 billion$19.58 billion15.56
DaVita logo
DVA
DaVita
1.7$113.54flat$12.42 billion$11.39 billion17.02
Sotera Health logo
SHC
Sotera Health
2.0$25.29flat$7.15 billionN/A0.00News Coverage
Progyny logo
PGNY
Progyny
1.5$50.42flat$4.40 billion$229.68 million458.36Insider Selling
Tivity Health logo
TVTY
Tivity Health
1.0$23.79flat$1.17 billion$1.13 billion-2.15
Ontrak logo
OTRK
Ontrak
1.7$30.69flat$542.91 million$35.10 million-18.05
SOC Telemed logo
TLMD
SOC Telemed
1.6$6.65flat$510.54 millionN/A0.00
Viemed Healthcare logo
VMD
Viemed Healthcare
1.1$9.34flat$365.99 million$80.26 million12.97
HemaCare logo
HEMA
HemaCare
0.5$25.31flat$346.52 millionN/A0.00News Coverage
Caladrius Biosciences logo
CLBS
Caladrius Biosciences
1.5$1.56flat$92.82 millionN/A-2.44Decrease in Short Interest
News Coverage
Cryo-Cell International logo
CCEL
Cryo-Cell International
0.9$9.92flat$75.10 million$31.80 million24.80Insider Buying
High Trading Volume
News Coverage
Baudax Bio logo
BXRX
Baudax Bio
1.4$1.06flat$74.35 millionN/A-0.30Analyst Downgrade
GRNV
GreenVision Acquisition
0.3$10.15flat$72.96 millionN/A0.00High Trading Volume
Emmaus Life Sciences logo
EMMA
Emmaus Life Sciences
0.2$1.28flat$62.70 million$1.32 million0.00
PFHOD
Pacific Health Care Organization
0.5$1.25flat$52.48 million$6.80 million0.00Gap Up
CTYX
Curative Biotechnology
0.0$0.11flat$40.17 millionN/A0.00
BioRestorative Therapies logo
BRTX
BioRestorative Therapies
0.6$0.01flat$17.38 million$110,000.000.00Gap Down
BRTXQ
BioRestorative Therapies
0.0$0.01flat$16.89 million$110,000.00-0.01
PFHO
Pacific Health Care Organization
0.8$1.12flat$14.53 million$7.33 million0.00Gap Up
GNOW
American Caresource
0.7$0.01flat$124,000.00N/A0.00
QMED
QMed
0.2$0.00flat$0.00N/A0.00
This page was last updated on 4/21/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.